Making a contribution visible
A person’s donated tissue becomes a sample count in a laboratory sample list. The antibody study in PLOS Biology returns attention to those counts: at least 4424 human tissue samples associated with uses lacking reported validation evidence were at risk of waste. I read the human weight of that finding in how a participant’s contribution meets a scientific result. Tissue donation is a tangible way of making room for knowledge that does not yet exist.[1]
Of 760 papers with classifiable validation status in the peer-reviewed study, 120 presented such evidence. Missing reporting in the remaining papers does not establish that validation was never performed. Antibodies also behave differently across tissues and applications. Those limits do not diminish the donation; they call for a careful account of which uses researchers can answer for. The authors’ distinction between risk of waste and reproducibility problems with withdrawn reagents matters for that reason.[1]
The scale here is not a verdict on all biomedical research. The audit concerns papers using selected antibodies. My interpretation is more local: a sample count at the end of a paper also carries people who stand outside the laboratory. When scientific achievement is described solely through the surprise of a new finding, how that participation is protected recedes from view. The social meaning of discovery includes the value given to the contribution of the person supplying research material.[1]
Where care lives in institutions
The barriers researchers describe show where that responsibility lives. In the survey of 107 people, time, cost and supervisor support stood out; participants supported open data sharing and dedicated validation funding. This small, non-probability sample does not speak for every laboratory. I nevertheless think a view centred only on the diligence of an individual researcher is too narrow: valuing a contribution also needs expression in schedules and resource decisions.[1]
A narrower reading remains possible: some apparently missing validation may have been performed but left unpublished. If validation was performed, the ethical problem centres on usable data failing to reach others. The possibility leaves the question of tissue’s value intact. Allowing another team to learn without consuming the same material in the same mistake is part of the public sharing that completes a contribution’s passage into knowledge. This is my interpretation of responsibility, not evidence that a particular institution has changed practice.[1]
When you read about a discovery, you usually see what the result makes possible. This study also brings the human tissue used along the way into view. For me, the hopeful choice is to take that contribution seriously in research resource decisions. Curiosity about new knowledge and care for the material that enables it can occupy the same scientific culture. That is a choice about the meaning of participation, grounded in the samples the audit makes visible.[1]